Eurobio Scientific : 2022 ANNUAL RESULTS – Very strong performance and strengthening of the Core Business
2022 ANNUAL RESULTS Very strong performance and strengthening of the Core Business Core Business1 revenues up 15% to €93.5M (+53%...
Year: 2023
HFMA Names Ann Jordan as New CEO
CHICAGO, April 05, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) announced today that its board of directors...
Reunion Rehabilitation Hospital Peoria Names Shawn McCallum Chief Executive Officer
Shawn McCallum, CEO - Reunion Rehabilitation Hospital Peoria Reunion Rehabilitation Hospital Peoria announced Shawn McCallum as its new CEO. PEORIA,...
Reunion Rehabilitation Hospital Arlington Names Rob Smart Chief Executive Officer
Rob Smart, CEO - Reunion Rehabilitation Hospital Arlington Reunion Rehabilitation Hospital Arlington announced Rob Smart as its new CEO.ARLINGTON, Texas,...
Brain Power Wellness Recaps Certified Teacher Leader Retreat
Brain Power Wellness is excited to share that it recently held another successful Certified Teacher Leader Retreat for thirty participants...
WellnessSpace Brands Implements API Integration to ABC Fitness Solutions
The new service allows customers that use ABC Fitness Solutions to access the products on demand, without assistance from staffCLEARWATER,...
What Does Ginseng Have to Do With Libido?
Male Plus Uses the Renowned Botanical to Set the Stage for Satisfying IntercourseFORT LAUDERDALE, FL, April 05, 2023 (GLOBE NEWSWIRE)...
The Brand Extending Intimacy With Natural Ingredients
Male Plus’s Unique Combination of Tribulus Terrestris, Maca Root, and Siberian Ginseng Is an Effective Alternative to Stronger Chemical Libido...
OXOS Medical Raises $23M Series A to Deliver “Radiology Department in a Box” to the Entire Healthcare Value Chain
Co-led by Parkway Venture Capital and Intel Capital, OXOS will leverage funds to expand into clinical, mobile, and home care...
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
IRVINE, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement...
Celularity Inc. Announces $6 Million Registered Direct Offering
FLORHAM PARK, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic...
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial of GD2-SADA
NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease
ILAP Designation accelerates patient access and commercializationMIAMI, April 05, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”),...
Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148
Enrollment triggers milestone payment Carlsbad, CA and Shanghai, China, April 05, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or...
CytoDyn to Hold Webcast to Provide a Company Update
VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
Glen Rock, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a...
Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt
SOUTH SAN FRANCISCO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company...
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands Highly Accretive Transformative Deal Utilizes...
Bioventus Announces CEO Leadership Change
DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
Immuneering to Present Initial Phase 1 Pharmacokinetic, Pharmacodynamic Modeling and Safety Data for Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023
- Investor call to be held at 9:00 a.m. ET on April 18, 2023 -CAMBRIDGE, Mass., April 05, 2023 (GLOBE...